First-Line Treatment for Bacterial Upper Respiratory Infection
For an otherwise healthy adult with bacterial upper respiratory infection (specifically acute bacterial rhinosinusitis), amoxicillin-clavulanate is the preferred first-line antibiotic, with amoxicillin alone as an acceptable alternative for mild disease without risk factors. 1
Treatment Algorithm
Step 1: Confirm Bacterial Etiology
Before prescribing antibiotics, ensure the infection meets criteria for bacterial (not viral) URI:
- Symptoms persisting ≥10 days without improvement, OR
- Severe symptoms (fever ≥38.3°C/101°F AND purulent nasal discharge or facial pain) for ≥3 consecutive days, OR
- "Double worsening" - initial improvement followed by worsening symptoms 1, 2
Critical pitfall: Most URIs are viral and do not require antibiotics. The common cold, influenza, and acute bronchitis in healthy adults should NOT be treated with antibiotics 2, 3.
Step 2: Choose Appropriate Antibiotic
For Acute Bacterial Rhinosinusitis (ABRS):
First-Line Options:
Amoxicillin-clavulanate is preferred when ANY of these risk factors exist 1:
- Antibiotic use in past 4-6 weeks
- Moderate-to-severe symptoms
- Age >65 years
- Comorbidities (diabetes, chronic cardiac/hepatic/renal disease, immunocompromised)
- Geographic areas with high penicillin-resistant S. pneumoniae (>10%)
- Recent hospitalization
- Smoker or household contact with smoker
Dosing:
- Standard: 1.75-4 g/250 mg daily 4
- High-dose: 2 g orally twice daily or 90 mg/kg/day divided twice daily for high-risk patients 1
Amoxicillin alone may be used for:
The 2015 guideline specifically recommends considering amoxicillin-clavulanate over amoxicillin alone due to coverage of beta-lactamase producing organisms (H. influenzae and M. catarrhalis) 1.
Step 3: Penicillin Allergy Alternatives
For non-Type I hypersensitivity (e.g., rash):
- Doxycycline, OR
- Respiratory fluoroquinolone (levofloxacin or moxifloxacin) 1
For Type I hypersensitivity:
- Respiratory fluoroquinolone (levofloxacin or moxifloxacin), OR
- Doxycycline 1
Important caveat: Macrolides (azithromycin, clarithromycin) and trimethoprim-sulfamethoxazole are NOT recommended as first-line therapy due to high resistance rates: >40% for macrolides against S. pneumoniae and 50% resistance to TMP-SMX 1. These should only be used in beta-lactam allergic patients when fluoroquinolones are contraindicated.
Step 4: Duration and Follow-up
- Treatment duration: 5-10 days (shorter courses of 5 days show similar efficacy with fewer adverse events) 1
- Reassess at 72 hours: If no improvement or worsening, consider switching antibiotics or reevaluating diagnosis 4, 5
- Adverse events occur in 15-40% of patients (GI symptoms most common), but rarely require treatment discontinuation 1
Key Clinical Distinctions
Do NOT treat with antibiotics:
- Common cold/viral URI 2, 3
- Acute bronchitis in healthy adults 6
- Symptoms <10 days without worsening 1, 2
Watchful waiting is appropriate for uncomplicated ABRS with mild symptoms (pain mild, fever <38.3°C) when follow-up is assured, as spontaneous resolution occurs in approximately 62% of cases 5, 7.
Fluoroquinolones should be reserved for treatment failures or penicillin-allergic patients, not used as first-line therapy, to preserve their effectiveness and minimize resistance development 1, 4.